Cognitive Stimulation for Elderly Bipolar Patients (TONIC)

  • STATUS
    Recruiting
  • End date
    Mar 15, 2023
  • participants needed
    40
  • sponsor
    Groupe Hospitalier de la Rochelle Ré Aunis
Updated on 23 March 2022
cognitive impairment
neurodegenerative disorders
cognitive disorder
cognitive stimulation

Summary

Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.

Description

Bipolar disorders, which belong to the category of mood disorders, are the 6th leading cause of disability in the world. Cognitive disorders are known to exist during the phases of bipolar disease, and alterations increase significantly after the age of 65. Recent studies have shown that attention, memory and executive function impairments are the main causes of cognitive disorders. Residual symptoms have a significant impact on the risk of relapse into bipolar disorder and on quality of life. Cognitive stimulation (CS) is a pedagogical approach based on the idea that cognitive skills contribute to personal development in the same way as psychological and social factors. This study aims at assessing a cognitive stimulation program initially developed for patients with neurodegenerative diseases, and adapted to bipolar disease. This program will be compared to the usual practice consisting in consultation with psychiatrist and sometimes in intervention of home nurses.

Details
Condition Bipolar Disorder, Cognitive Impairment, Age-related Cognitive Decline
Treatment Cognitive Stimulation
Clinical Study IdentifierNCT04184375
SponsorGroupe Hospitalier de la Rochelle Ré Aunis
Last Modified on23 March 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

age > 65 years old
Diagnosis of bipolar illness for more than 10 years
Euthymic phase
Understands and speaks French
Free, informed and express consent
Inclusion Criteria
Mild to moderate neuro-cognitive impairments (MMS Test : 16 ≤ score < 26)

Exclusion Criteria

Illiteracy
Patient participating in other therapeutic workshops (e. g. psycho-geriatric day hospital care, etc.)
Persons deprived of their liberty by a judicial or administrative decision
Persons of full age who are subject to a legal protection measure
Persons unable to consent
Persons who are not members of or beneficiaries of a social security scheme
Patient's refusal to participate in the study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note